Back
Pacira BioSciences 10K Form
Sell
33
PCRX
Pacira BioSciences
Last Price:
14.50
Seasonality Move:
-2.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PCRX News And Ratings
See the #1 stock for the next 7 days that we like better than PCRX
PCRX Financial Statistics
Sales & Book Value
Annual Sales: | $674.98M |
---|---|
Cash Flow: | $51.65M |
Price / Cash Flow: | 4.4 |
Annual Sales: | $19.07 |
Price / Book: | 0.76 |
Profitability
EPS (TTM): | 1.33000 |
---|---|
Net Income (TTM): | $63.59M |
Gross Margin: | $490.31M |
Return on Equity: | 7.43% |
Return on Assets: | 4.03% |
Pacira BioSciences Earnings Forecast
Key Pacira BioSciences Financial Ratios
- The Gross Profit Margin over the past 16 years for PCRX is 72.64%.
- The Selling, General & Administrative Expenses for PCRX have been equal to 39.92% of Gross Profit Margin.
- The Research & Development expenses have been 11.30% of Revenue.
- The Interest Expense is 41.26% of Operating Income.
- The Net Earning history of PCRX is 6.22% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 8 years.
Pacira BioSciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | PCRX |
CUSIP: | 695127 |
Website: | pacira.com |
Debt
Debt-to-Equity Ratio: | 0.67 |
---|---|
Current Ratio: | 6.82 |
Quick Ratio: | 5.49 |
Price-to-Earnings
Trailing P/E Ratio: | 16.31 |
---|---|
Forward P/E Ratio: | 4.81 |
PCRX Technical Analysis vs Fundamental Analysis
Sell
33
Pacira BioSciences (PCRX)
is a Sell
Is Pacira BioSciences a Buy or a Sell?
-
Pacira BioSciences stock is rated a Sell
The current Pacira BioSciences [PCRX] share price is $14.52. The Score for PCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.